Phase II study with prolonged infusion gemcitabine in pretreated advanced soft tissue sarcomas of the adult

被引：1
|
作者：
Späth-Schwalbe, E
Genvresse, I
Koschuth, A
Grunewald, R
Possinger, K
机构：
[1] Charite Univ Hosp, Berlin, Germany
[2] Humboldt Univ, Berlin, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81503-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1083
引用
收藏
页码：S271 / S271
页数：1
相关论文
共 50 条
  • [31] Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study
    Peter Schmid
    Marcus Schweigert
    Thomas Beinert
    Bernd Flath
    Orhan Sezer
    Kurt Possinger
    [J]. Investigational New Drugs, 2005, 23 : 139 - 146
  • [32] Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients
    Yovine, A
    Riofrio, M
    Blay, JY
    Brain, E
    Alexandre, J
    Kahatt, C
    Taamma, A
    Jimeno, J
    Martin, C
    Salhi, Y
    Cvitkovic, E
    Misset, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 890 - 899
  • [33] Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study
    Schmid, P
    Schweigert, M
    Beinert, T
    Flath, B
    Sezer, O
    Possinger, K
    [J]. INVESTIGATIONAL NEW DRUGS, 2005, 23 (02) : 139 - 146
  • [34] An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma
    Hartmann, JT
    Oechsle, K
    Huober, J
    Jakob, A
    Azemar, M
    Horger, M
    Kanz, L
    Bokemeyer, C
    [J]. INVESTIGATIONAL NEW DRUGS, 2006, 24 (03) : 249 - 253
  • [35] An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma
    J. T. Hartmann
    K. Oechsle
    J. Huober
    A. Jakob
    M. Azemar
    M. Horger
    L. Kanz
    C. Bokemeyer
    [J]. Investigational New Drugs, 2006, 24 : 249 - 253
  • [36] Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomas
    De Pas, T
    Curigliano, G
    Masci, G
    Catania, C
    Comandone, A
    Boni, C
    Tucci, A
    Pagani, O
    Marrocco, E
    de Braud, F
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (01) : 161 - 166
  • [37] PHASE-II TRIAL OF METHYLENE DIMETHANE SULFONATE (MDMS) IN ADVANCED SOFT-TISSUE SARCOMAS OF THE ADULT
    STEWARD, WP
    MOURIDSEN, HT
    KERBRAT, P
    SOMERS, R
    VERWEIJ, J
    VANOOSTEROM, AT
    BLACKLEDGE, G
    HAVSTEEN, H
    THOMAS, D
    SYLVESTER, R
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (08): : 1251 - 1253
  • [38] Phase II Trial of Liposomal Doxorubicin (Doxil®) in Advanced Soft Tissue Sarcomas
    T. Chidiac
    G.T. Budd
    R. Pelley
    K. Sandstrom
    D. McLain
    P. Elson
    R. Crownover
    K. Marks
    G. Muschler
    M. Joyce
    R. Zehr
    R. Bukowski
    [J]. Investigational New Drugs, 2000, 18 : 253 - 259
  • [39] Neoadjuvant chemotherapy for adult soft tissue sarcomas: A phase II trial.
    Aguiar, Samuel
    Ferreira, Fabio Oliveira
    Sobreira Batista, Ranyell Spencer
    Bressan, Alexsander Kurowa
    Mello, Celso Lopes
    Lopes, Ademar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Phase II trial of liposomal doxorubicin (Doxil®) in advanced soft tissue sarcomas
    Chidiac, T
    Budd, GT
    Pelley, R
    Sandstrom, K
    McLain, D
    Elson, P
    Crownover, R
    Marks, K
    Muschler, G
    Joyce, M
    Zehr, R
    Bukowski, R
    [J]. INVESTIGATIONAL NEW DRUGS, 2000, 18 (03) : 253 - 259
12345